Andrew Payne

Prix à l'honneur

Legal 500

Intellectual Property: patents (contentious & non-contentious) - "Andrew has been identified as a key name to note."

Andrew is a partner in the Patents & Innovation team and offers expert counsel on contentious patent and regulatory matters.

Leveraging his previous experience as a medicinal chemist in the pharmaceutical industry, he is particularly focused on advising companies within the life sciences sector and is recognised by clients for his extensive industry knowledge.

CV

Since 2025 Partner, Taylor Wessing

2024 - 2025 Senior Counsel, Taylor Wessing

2020 - 2024 Senior Associate, Taylor Wessing

Carrière

Since 2025 Partner, Taylor Wessing

2024 - 2025 Senior Counsel, Taylor Wessing

2020 - 2024 Senior Associate, Taylor Wessing

Formation

2015 Admitted as a lawyer, England & Wales

2013 LPC distinction, BPP Law School

2011 GDL commendation, BPP Law School, London

Publications

Declaratory Relief in the English Patents Court, Bio-Science Law Review, 2016, p 123-128
Patents Overhauled: Impact of the America Invents Act on the Pharmaceutical Industry (co-author), European Biopharmaceutical Review, Spring 2015
New and Approved: The New EU Clinical Trials Regulation (co-author), European Pharmaceutical Contractor, December 2014 p 50-53